Literature DB >> 19067022

Genetic epidemiology of Paget's disease of bone in italy: sequestosome1/p62 gene mutational test and haplotype analysis at 5q35 in a large representative series of sporadic and familial Italian cases of Paget's disease of bone.

Alberto Falchetti1, Marco Di Stefano, Francesca Marini, Sergio Ortolani, Massimo Fabio Ulivieri, Simona Bergui, Laura Masi, Chiara Cepollaro, Maurizio Benucci, Ombretta Di Munno, Maurizio Rossini, Silvano Adami, Antonio Del Puente, Giancarlo Isaia, Francesca Torricelli, Maria Luisa Brandi.   

Abstract

Families affected by Paget's disease of bone frequently harbor mutations in the SQSTM1/p62 gene. In this multicentric study we collected 345 sporadic and 12 familial PDB cases throughout Italy, identifying 12 different mutations, 5 of which are newly reported and 3, D335E, A381V, and Y383X, external to the UBA domain. Subjects with truncating mutations, E396X, showed a significantly younger age at clinical diagnosis, while the Y383X subjects had a higher average number of affected skeletal sites. All the mutants exhibited the CGTG-H2 haplotype. In two pairs and one triad of unrelated Italian PDB families from different Italian regions, we detected a common SQSTM1/p62 mutation for each P392L, M404V, and G425R group. Since the CGTG-H2 haplotype frequency was also high in normal subjects, and genetic influence due to migratory fluxes of different ethnic groups exists in the Italian population, to refine the search for a more geographically specific founder effect, we extended the haplotype analysis in these families using polymorphic microsatellite repeat markers, within and flanking the SQSTM1/p62 locus, from chromosome 5q35, other than the exon 6 and 3'UTR polymorphisms. All mutant carriers from two of the three M404V families and from the G425R families exhibited common extended chromosome 5q35 haplotypes, IT01 and IT02, respectively, which may be reflecting influences of past migrations. This may be helpful in estimating the true rate of de novo mutations. We confirm the data on the existence of both a mutational hotspot at the UBA domain of SQSTM1/p62 and a founder effect in the PDB population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19067022     DOI: 10.1007/s00223-008-9192-8

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  12 in total

1.  The majority of the genetic risk for Paget's disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genes.

Authors:  Pui Yan Jenny Chung; Greet Beyens; Steven Boonen; Socrates Papapoulos; Piet Geusens; Marcel Karperien; Filip Vanhoenacker; Leon Verbruggen; Erik Fransen; Jan Van Offel; Stefan Goemaere; Hans-Georg Zmierczak; René Westhovens; Jean-Pierre Devogelaer; Wim Van Hul
Journal:  Hum Genet       Date:  2010-09-14       Impact factor: 4.132

2.  The Implications of the Sequestosome 1 Mutation P392L in Patients with Paget's Disease in a United States Cohort.

Authors:  Margaret Seton; Marc Hansen; Daniel H Solomon
Journal:  Calcif Tissue Int       Date:  2015-12-28       Impact factor: 4.333

3.  Genome-wide association identifies three new susceptibility loci for Paget's disease of bone.

Authors:  Omar M E Albagha; Sachin E Wani; Micaela R Visconti; Nerea Alonso; Kirsteen Goodman; Maria Luisa Brandi; Tim Cundy; Pui Yan Jenny Chung; Rosemary Dargie; Jean-Pierre Devogelaer; Alberto Falchetti; William D Fraser; Luigi Gennari; Fernando Gianfrancesco; Michael J Hooper; Wim Van Hul; Gianluca Isaia; Geoff C Nicholson; Ranuccio Nuti; Socrates Papapoulos; Javier del Pino Montes; Thomas Ratajczak; Sarah L Rea; Domenico Rendina; Rogelio Gonzalez-Sarmiento; Marco Di Stefano; Lynley C Ward; John P Walsh; Stuart H Ralston
Journal:  Nat Genet       Date:  2011-05-29       Impact factor: 38.330

4.  Giant cell tumor in a case of Paget's disease of bone: an aggressive benign tumor exhibiting a quick response to an innovative therapeutic agent.

Authors:  Roberta Cosso; Vincenzo Nuzzo; Alfonso Zuccoli; Maria Luisa Brandi; Alberto Falchetti
Journal:  Clin Cases Miner Bone Metab       Date:  2010-05

Review 5.  Paget's disease of bone-genetic and environmental factors.

Authors:  Frederick R Singer
Journal:  Nat Rev Endocrinol       Date:  2015-08-18       Impact factor: 43.330

Review 6.  Clinical and Genetic Advances in Paget's Disease of Bone: a Review.

Authors:  N Alonso; I Calero-Paniagua; J Del Pino-Montes
Journal:  Clin Rev Bone Miner Metab       Date:  2016-12-19

7.  Impact of the Endocannabinoid System on Bone Formation and Remodeling in p62 KO Mice.

Authors:  Christina Keller; Timur Alexander Yorgan; Sebastian Rading; Thorsten Schinke; Meliha Karsak
Journal:  Front Pharmacol       Date:  2022-03-22       Impact factor: 5.810

Review 8.  Genetic Determinants of Paget's Disease of Bone.

Authors:  Navnit S Makaram; Stuart H Ralston
Journal:  Curr Osteoporos Rep       Date:  2021-05-14       Impact factor: 5.096

Review 9.  Boning up on autophagy: the role of autophagy in skeletal biology.

Authors:  Irving M Shapiro; Robert Layfield; Martin Lotz; Carmine Settembre; Caroline Whitehouse
Journal:  Autophagy       Date:  2013-11-11       Impact factor: 16.016

10.  Paget disease of bone-associated UBA domain mutations of SQSTM1 exert distinct effects on protein structure and function.

Authors:  Alice Goode; Jed E Long; Barry Shaw; Stuart H Ralston; Micaela Rios Visconti; Fernando Gianfrancesco; Teresa Esposito; Luigi Gennari; Daniela Merlotti; Domenico Rendina; Sarah L Rea; Melanie Sultana; Mark S Searle; Robert Layfield
Journal:  Biochim Biophys Acta       Date:  2014-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.